Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease (Q40737427)

23 September 2017

Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease (English)

1 reference

23 September 2017

1 reference

Wang L

1

1 reference

23 September 2017

Muramatsu S

2

1 reference

23 September 2017

Lu Y

3

1 reference

23 September 2017

Ikeguchi K

4

1 reference

23 September 2017

Fujimoto K

5

1 reference

23 September 2017

Okada T

6

1 reference

23 September 2017

Mizukami H

7

1 reference

23 September 2017

Hanazono Y

8

1 reference

23 September 2017

Kume A

9

1 reference

23 September 2017

Urano F

10

1 reference

23 September 2017

Ichinose H

11

1 reference

23 September 2017

Nagatsu T

12

1 reference

23 September 2017

Nakano I

13

1 reference

23 September 2017

Ozawa K

14

1 reference

23 September 2017

1 March 2002

1 reference

23 September 2017

1 reference

23 September 2017

9

1 reference

23 September 2017

6

1 reference

23 September 2017

381-389

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301682

23 September 2017

0 references

cites work

Prospects for new restorative and neuroprotective treatments in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Parkinson's disease: a neurodegenerative disease particularly amenable to gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Dopaminergic neurons protected from degeneration by GDNF gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

AAV vectors: is clinical success on the horizon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

A mathematical model of pathogenesis in idiopathic parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Differential expression of mRNAs of GDNF family in the striatum following 6-OHDA-induced lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Prevention of dopaminergic neuron death by adeno-associated virus vector-mediated GDNF gene transfer in rat mesencephalic cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Cloning and structural organization of the gene encoding the mouse glial cell line-derived neurotrophic factor, GDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Adeno-associated virus vectors can be efficiently produced without helper virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

7 January 2021

Double immunocytochemistry for the detection of Fos protein in retrogradely identified neurons using cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

7 January 2021

Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

7 January 2021

Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

7 January 2021

Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

7 January 2021

Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301682

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301682

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference